SALIX PHARMACEUTICALS LTD
Raleigh, NC · CIK 0001009356 · Biotech · Acquired
Specialty pharmaceutical treatments for gastrointestinal diseases
salix.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $750M
- 1 Form D · Jan 2014
- 153 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 40
- 13 granted · 27 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20132014
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $750,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2380 | MANUS BIO INC | — | $109M |
| 2381 | Jaguar Health, Inc. | — | $146M |
| 2382 | MediWound Ltd. | — | $31M |
| 2383 | SALIX PHARMACEUTICALS LTD | — | $750M |
| 2384 | Stemsynergy Therapeutic | — | — |
| 2385 | HiberCell | — | — |
| 2386 | RaeSedo, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- John ChappellDirector
- Thomas D'AlonzoDirector
- Adam DerbyshireExecutive Officer
- William ForbesExecutive Officer
- William KeaneDirector
- Carolyn LoganDirector · Executive Officer
- Rick ScruggsExecutive Officer
- Mark SirgoDirector
Patents
- Methods For Treatment And Prevention Of Opioid Induced Constipation Using Oral Compositions Of Methylnaltrexoneapplication
- Methods Of Treating Hepatic Encephalopathygranted
- Methods Of Treating Hepatic Encephalopathygranted
- Methods Of Treating Hepatic Encephalopathygranted
- Use Of Aminosalicylates In Diarrhoea-predominent Irritable Bowel Syndromegranted
- Methods For Treating Irritable Bowel Syndrome (ibs)granted
- Methods Of Treating Hepatic Encephalopathygranted
- Formulations Of Rifaximin And Uses Thereofapplication
- Forms Of Rifaximin And Uses Thereofgranted
- Methods Of Treating Hepatic Encephalopathygranted
- Methods Of Treating Traveler's Diarrhea And Hepatic Encephalopathygranted
- Formulations Of Rifaximin And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.